DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 06 · Volume 23 · December 1997 DOI: 10.1055/s-002-7352

  • 491
    Fenton, John W.:

    Preface

  • 493
    Okamoto, Shosuke; Hijikata-Okunomiya, Akiko; Wanaka, Keiko; Okada, Yoshio; Okamoto, Utako:

    Enzyme-Controlling Medicines: Introduction

  • 503
    Hursting, Marcie J.; Alford, Kenneth L.; Becker, Jeanclaude P.; Brooks, R. Lynn; Joffrion, James L.; Knappenberger, Gary D.; Kogan, Patricia W.; Kogan, Timothy P.; Mckinney, Anthony A.; Schwarz, Richard P.:

    Novastan® (Brand of Argatroban): A Small-Molecule, Direct Thrombin Inhibitor

  • 517
    Matsuo, Takefumi; Koide, Masanobu; Kario, Kazuomi:

    Development of Argatroban, a Direct Thrombin Inhibitor, and Its Clinical Application

  • 523
    Tamao, Yoshikuni; Kikumoto, Ryoji:

    Effect of Argatroban, a Selective Thrombin Inhibitor, on Animal Models of Cerebral Thrombosis

  • 531
    Kobayashi, Shotai; Tazaki, Yoshiaki:

    Effect of the Thrombin Inhibitor Argatroban in Acute Cerebral Thrombosis

  • 535
    Uchiyama, Shinichiro; Yamazaki, Masako; Hara, Yukiko; Iwata, Makoto:

    Alterations of Platelet, Coagulation, and Fibrinolysis Markers in Patients with Acute Ischemic Stroke

  • 543
    Jafri, Syed M.:

    Hypercoagulability in Heart Failure

  • 547
    Smith, Roy E.:

    The INR: A Perspective

  • 551
    Dickerson, Malcolm J.:

    Is Low AT III a Significant Risk Factor for Coronary Artery Disease? Anecdotal Observations

  • 557
    Sakuragawa, Nobuo:

    Regulation of Thrombosis and Hemostasis by Antithrombin

  • 563
    Malviya, Shobha:

    Monitoring and Management of Anticoagulation in Children Requiring Extracorporeal Circulation

  • 569
    Alving, Barbara M.; Krishnamurti, Chitra:

    Recognition and Management of Heparin-Induced Thrombocytopenia (HIT) and Thrombosis

  • 575
    Bates, Eric R.:

    Clinical Trial Results with Hirudin and Bivalirudin for Acute Coronary Artery Syndromes

  • 583
    Uchiba, Mitsuhiro; Okajima, Kenji:

    Antithrombin III (AT III) Prevents LPS-Induced Pulmonary Vascular Injury: Novel Biological Activity of AT III

  • 591
    Haire, William D.:

    Antithrombin III in Hematopoietic Stem Cell Transplantation

  • 603
    W, E.:

    Abstracts of Current Literature